⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL396976 | 0.97 | — | — | |
| SCHEMBL3534488 | 0.94 | — | — | |
| SCHEMBL273580 | 0.87 | — | — | |
| SCHEMBL1488097 | 0.75 | — | — | |
| SCHEMBL1679662 | 0.73 | ADH1B (0.55) | — | |
| SCHEMBL18225062 | 0.73 | — | — | |
| SCHEMBL25047164 | 0.71 | ADH1B (0.59) | — | |
| SCHEMBL1679009 | 0.71 | ADH1B (0.52) | — | |
| SCHEMBL1679033 | 0.71 | ADH1B (0.59) | — | |
| SCHEMBL18849498 | 0.71 | ADH1B (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160145242-A1 | PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC. | NIPPON SODA CO., LTD. (JP) | 2016-05-26 | — | — | US | disclosed |
| EP-2998298-A1 | PHENYLIMIDAZOLE DERIVATIVE, AND THERAPEUTIC MEDICINE OR PREVENTIVE MEDICINE FOR INFLAMMATORY DISEASE, ETC. | Nippon Soda Co., Ltd. (JP) | 2016-03-23 | — | — | EP | disclosed |
| EP-0870765-B1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-5981557-A | HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0870765-A1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| US-5569665-A | Peptidyl derivatives and their use as metalloproteinases inhibitors | CELLTECH LIMITED (GB) | 1996-10-29 | — | — | US | disclosed |
| US-5530128-A | ENZYME INHIBITOR AS ANTITUMOR AGENT | CELLTECH THERAPEUTICS LIMITED (GB) | 1996-06-25 | — | — | US | disclosed |
| EP-0489577-B1 | Peptidyl derivatives | CELLTECH LTD (GB) | 1995-03-22 | — | — | EP | disclosed |
| EP-0605682-A1 | PEPTIDYL DERIVATIVES AND THEIR USE AS METALLOPROTEINASES INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-07-13 | — | — | EP | disclosed |
| EP-0605681-A1 | SULPHAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-07-13 | — | — | EP | disclosed |
| US-5300501-A | Metalloproteinase inhibitors | CELLTECH LIMITED (GB) | 1994-04-05 | — | — | US | disclosed |
| WO-1993024475-A1 | SULPHAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | CELLTECH LIMITED (GB) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993024449-A1 | PEPTIDYL DERIVATIVES AND THEIR USE AS METALLOPROTEINASES INHIBITORS | CELLTECH LIMITED (GB) | 1993-12-09 | — | — | WO | disclosed |
| WO-1992009565-A1 | PEPTIDYL DERIVATIVES | CELLTECH LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| EP-0489577-A1 | Peptidyl derivatives | CELLTECH LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |